Regulation of mTORC1 and its impact on gene expression at a glance
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bakan, 2012, Connecting mTORC1 signaling to SREBP-1 activation., Curr. Opin. Lipidol., 23, 226, 10.1097/MOL.0b013e328352dd03
Bar-Peled, 2012, Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1., Cell, 150, 1196, 10.1016/j.cell.2012.07.032
Bentzinger, 2008, Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy., Cell Metab., 8, 411, 10.1016/j.cmet.2008.10.002
Blommaart, 1995, Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes., J. Biol. Chem., 270, 2320, 10.1074/jbc.270.5.2320
Brown, 1994, A mammalian protein targeted by G1-arresting rapamycin-receptor complex., Nature, 369, 756, 10.1038/369756a0
Brugarolas, 2003, TSC2 regulates VEGF through mTOR-dependent and -independent pathways., Cancer Cell, 4, 147, 10.1016/S1535-6108(03)00187-9
Cho, 2004, Regulation of adipocyte differentiation and insulin action with rapamycin., Biochem. Biophys. Res. Commun., 321, 942, 10.1016/j.bbrc.2004.07.050
Crespo, 2002, Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae., Microbiol. Mol. Biol. Rev., 66, 579, 10.1128/MMBR.66.4.579-591.2002
Cunningham, 2007, mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex., Nature, 450, 736, 10.1038/nature06322
Dibble, 2012, TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1., Mol. Cell, 47, 535, 10.1016/j.molcel.2012.06.009
Düvel, 2010, Activation of a metabolic gene regulatory network downstream of mTOR complex 1., Mol. Cell, 39, 171, 10.1016/j.molcel.2010.06.022
Efeyan, 2013, Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival., Nature, 493, 679, 10.1038/nature11745
Gagnon, 2001, Rapamycin-sensitive phase of 3T3-L1 preadipocyte differentiation after clonal expansion., J. Cell. Physiol., 189, 14, 10.1002/jcp.1132
Goncharova, 2009, Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis., Mol. Pharmacol., 76, 766, 10.1124/mol.109.057042
Hannan, 2003, mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF., Mol. Cell. Biol., 23, 8862, 10.1128/MCB.23.23.8862-8877.2003
Hara, 1998, Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism., J. Biol. Chem., 273, 14484, 10.1074/jbc.273.23.14484
Harrison, 2009, Rapamycin fed late in life extends lifespan in genetically heterogeneous mice., Nature, 460, 392, 10.1038/nature08221
Horton, 2002, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver., J. Clin. Invest., 109, 1125, 10.1172/JCI0215593
Hsu, 2011, The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling., Science, 332, 1317, 10.1126/science.1199498
Hudson, 2002, Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin., Mol. Cell. Biol., 22, 7004, 10.1128/MCB.22.20.7004-7014.2002
Inoki, 2002, TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling., Nat. Cell Biol., 4, 648, 10.1038/ncb839
Inoki, 2003, Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling., Genes Dev., 17, 1829, 10.1101/gad.1110003
Jacinto, 2004, Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive., Nat. Cell Biol., 6, 1122, 10.1038/ncb1183
Jimenez, 2010, Regulation of gene expression in hepatic cells by the mammalian Target of Rapamycin (mTOR)., PLoS ONE, 5, e9084, 10.1371/journal.pone.0009084
Kantidakis, 2010, mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1., Proc. Natl. Acad. Sci. USA, 107, 11823, 10.1073/pnas.1005188107
Keith, 2012, HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression., Nat. Rev. Cancer, 12, 9, 10.1038/nrc3183
Khamzina, 2005, Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance., Endocrinology, 146, 1473, 10.1210/en.2004-0921
Kim, 2004, regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis., Diabetes, 53, 2748, 10.2337/diabetes.53.11.2748
Kim, 1998, ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand., Proc. Natl. Acad. Sci. USA, 95, 4333, 10.1073/pnas.95.8.4333
Kim, 2008, Regulation of TORC1 by Rag GTPases in nutrient response., Nat. Cell Biol., 10, 935, 10.1038/ncb1753
Kim, 2009, Signal transducer and activator of transcription 3 (STAT3) mediates amino acid inhibition of insulin signaling through serine 727 phosphorylation., J. Biol. Chem., 284, 35425, 10.1074/jbc.M109.051516
Kim, 2012, S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver., Hepatology, 55, 1727, 10.1002/hep.25537
Kortylewski, 2005, Targeting STAT3 affects melanoma on multiple fronts., Cancer Metastasis Rev., 24, 315, 10.1007/s10555-005-1580-1
Koyanagi, 2011, Ablation of TSC2 enhances insulin secretion by increasing the number of mitochondria through activation of mTORC1., PLoS ONE, 6, e23238, 10.1371/journal.pone.0023238
Lamming, 2012, Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity., Science, 335, 1638, 10.1126/science.1215135
Laplante, 2012, mTOR signaling in growth control and disease., Cell, 149, 274, 10.1016/j.cell.2012.03.017
Laplante, 2012, DEPTOR cell-autonomously promotes adipogenesis, and its expression is associated with obesity., Cell Metab., 16, 202, 10.1016/j.cmet.2012.07.008
Laughner, 2001, HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression., Mol. Cell. Biol., 21, 3995, 10.1128/MCB.21.12.3995-4004.2001
Le Bacquer, 2007, Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2., J. Clin. Invest., 117, 387, 10.1172/JCI29528
Lefebvre, 2006, Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis., J. Clin. Invest., 116, 571, 10.1172/JCI27989
Li, 2010, Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis., Proc. Natl. Acad. Sci. USA, 107, 3441, 10.1073/pnas.0914798107
Li, 2011, Role of S6K1 in regulation of SREBP1c expression in the liver., Biochem. Biophys. Res. Commun., 412, 197, 10.1016/j.bbrc.2011.07.038
Ma, 2005, Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis., Cell, 121, 179, 10.1016/j.cell.2005.02.031
Ma, 2010, Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade., J. Clin. Invest., 120, 103, 10.1172/JCI37964
Majmundar, 2010, Hypoxia-inducible factors and the response to hypoxic stress., Mol. Cell, 40, 294, 10.1016/j.molcel.2010.09.022
Manning, 2007, AKT/PKB signaling: navigating downstream., Cell, 129, 1261, 10.1016/j.cell.2007.06.009
Manning, 2002, Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway., Mol. Cell, 10, 151, 10.1016/S1097-2765(02)00568-3
Martina, 2012, MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB., Autophagy, 8, 903, 10.4161/auto.19653
Mayer, 2004, mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability., Genes Dev., 18, 423, 10.1101/gad.285504
Menendez, 2007, Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis., Nat. Rev. Cancer, 7, 763, 10.1038/nrc2222
Miller, 2011, Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice., J. Gerontol., 66A, 191, 10.1093/gerona/glq178
Okuda, 1987, Age-related change in ketone body metabolism: diminished glucagon effect on ketogenesis in adult rats., Endocrinology, 120, 2152, 10.1210/endo-120-5-2152
Onda, 2002, Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway., Mol. Cell. Neurosci., 21, 561, 10.1006/mcne.2002.1184
Owen, 2012, Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase., Proc. Natl. Acad. Sci. USA, 109, 16184, 10.1073/pnas.1213343109
Palmieri, 2011, Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways., Hum. Mol. Genet., 20, 3852, 10.1093/hmg/ddr306
Peng, 2002, The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation., Mol. Cell. Biol., 22, 5575, 10.1128/MCB.22.15.5575-5584.2002
Petersen, 2003, Mitochondrial dysfunction in the elderly: possible role in insulin resistance., Science, 300, 1140, 10.1126/science.1082889
Peterson, 2011, mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway., Cell, 146, 408, 10.1016/j.cell.2011.06.034
Polak, 2008, Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration., Cell Metab., 8, 399, 10.1016/j.cmet.2008.09.003
Porstmann, 2008, SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth., Cell Metab., 8, 224, 10.1016/j.cmet.2008.07.007
Potter, 2002, Akt regulates growth by directly phosphorylating Tsc2., Nat. Cell Biol., 4, 658, 10.1038/ncb840
Roczniak-Ferguson, 2012, The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis., Sci. Signal., 5, ra42, 10.1126/scisignal.2002790
Romanino, 2011, Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function., Proc. Natl. Acad. Sci. USA, 108, 20808, 10.1073/pnas.1111448109
Rosen, 2006, Adipocyte differentiation from the inside out., Nat. Rev. Mol. Cell Biol., 7, 885, 10.1038/nrm2066
Roux, 2004, Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase., Proc. Natl. Acad. Sci. USA, 101, 13489, 10.1073/pnas.0405659101
Sabatini, 1994, RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs., Cell, 78, 35, 10.1016/0092-8674(94)90570-3
Sabers, 1995, Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells., J. Biol. Chem., 270, 815, 10.1074/jbc.270.2.815
Sancak, 2007, PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase., Mol. Cell, 25, 903, 10.1016/j.molcel.2007.03.003
Sancak, 2008, The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1., Science, 320, 1496, 10.1126/science.1157535
Sancak, 2010, Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids., Cell, 141, 290, 10.1016/j.cell.2010.02.024
Sanguino, 2004, Lack of hypotriglyceridemic effect of gemfibrozil as a consequence of age-related changes in rat liver PPARalpha., Biochem. Pharmacol., 67, 157, 10.1016/j.bcp.2003.08.034
Sarbassov, 2004, Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton., Curr. Biol., 14, 1296, 10.1016/j.cub.2004.06.054
Sarbassov, 2006, Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB., Mol. Cell, 22, 159, 10.1016/j.molcel.2006.03.029
Sarkar, 2008, Small molecule enhancers of autophagy for neurodegenerative diseases., Mol. Biosyst., 4, 895, 10.1039/b804606a
Sastre, 1996, Aging of the liver: age-associated mitochondrial damage in intact hepatocytes., Hepatology, 24, 1199, 10.1002/hep.510240536
Sengupta, 2010, mTORC1 controls fasting-induced ketogenesis and its modulation by ageing., Nature, 468, 1100, 10.1038/nature09584
Settembre, 2011, TFEB links autophagy to lysosomal biogenesis., Science, 332, 1429, 10.1126/science.1204592
Settembre, 2012, A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB., EMBO J., 31, 1095, 10.1038/emboj.2012.32
Shende, 2011, Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice., Circulation, 123, 1073, 10.1161/CIRCULATIONAHA.110.977066
Shor, 2010, Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells., J. Biol. Chem., 285, 15380, 10.1074/jbc.M109.071639
Singh, 2011, Autophagy in the cellular energetic balance., Cell Metab., 13, 495, 10.1016/j.cmet.2011.04.004
Tee, 2003, Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb., Curr. Biol., 13, 1259, 10.1016/S0960-9822(03)00506-2
Thedieck, 2007, PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis., PLoS ONE, 2, e1217, 10.1371/journal.pone.0001217
Tremblay, 2007, Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance., Proc. Natl. Acad. Sci. USA, 104, 14056, 10.1073/pnas.0706517104
Tzatsos, 2006, Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation., Mol. Cell. Biol., 26, 63, 10.1128/MCB.26.1.63-76.2006
Um, 2004, Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity., Nature, 431, 200, 10.1038/nature02866
Vander Haar, 2007, Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40., Nat. Cell Biol., 9, 316, 10.1038/ncb1547
Wang, 2007, PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding., J. Biol. Chem., 282, 20036, 10.1074/jbc.M702376200
Wang, 2011, The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile., Proc. Natl. Acad. Sci. USA, 108, 15201, 10.1073/pnas.1103746108
Weichhart, 2008, The TSC-mTOR signaling pathway regulates the innate inflammatory response., Immunity, 29, 565, 10.1016/j.immuni.2008.08.012
Yecies, 2011, Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways., Cell Metab., 14, 21, 10.1016/j.cmet.2011.06.002
Yokogami, 2000, Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR., Curr. Biol., 10, 47, 10.1016/S0960-9822(99)00268-7
Yu, 2008, Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells., Mol. Cell. Biochem., 310, 11, 10.1007/s11010-007-9661-9
Yu, 2011, Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling., Science, 332, 1322, 10.1126/science.1199484
Zhang, 2009, Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway., PLoS ONE, 4, e6189, 10.1371/journal.pone.0006189
Zhou, 2007, Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance., Proc. Natl. Acad. Sci. USA, 104, 16158, 10.1073/pnas.0702596104
Zinzalla, 2011, Activation of mTORC2 by association with the ribosome., Cell, 144, 757, 10.1016/j.cell.2011.02.014